Literature DB >> 15184197

Glutathione S-transferase variants and their interaction with smoking on lung function.

Jian-Qing He1, John E Connett, Nicholas R Anthonisen, Peter D Paré, Andrew J Sandford.   

Abstract

We studied glutathione S-transferase (GST) polymorphisms in 1,098 whites with the lowest (n = 544, FEV(1) % predicted mean +/- SEM = 62.6 +/- 0.1) and the highest (n = 554, FEV(1) % predicted mean +/- SEM = 91.8 +/- 0.1) lung function at the beginning of the Lung Health Study. Homozygosity for GSTP1 105Val was significantly more frequent in the low- than in the high-function group (13.2 vs. 9.3%) (odds ratio = 1.69, 95% confidence interval [CI] = 1.11-2.61, p = 0.016), after adjustment for confounding variables. Subjects with 105Val homozygotes had higher rates of lung function decline in the high-function group (p = 0.017). The frequencies of GSTM1, GSTT1 null genotypes were similar between the high- and low-function groups, but subjects with the GSTT1 null genotype had a faster decline of lung function in the low-function group (p = 0.032). In addition, there was a significant interaction of GSTT1 genotype and pack-years on lung function. When comparing individuals with GSTT1 null genotype with wild type, the adjusted odds ratio was 3.49 (95% CI, 1.48-8.39, p = 0.005) in mild smokers (< or = 25 pack years). We conclude that GST genotypes are risk factors for rapid decline or low lung function in smokers with mild to moderate airflow obstruction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184197     DOI: 10.1164/rccm.200312-1763OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

1.  Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate.

Authors:  Margareta Littorin; Saimei Hou; Karin Broberg; Jonas Björk; Susanne Fält; Galbani Abdoulaye; Malgorzata Kalemba; Charlotta Ryk; Staffan Skerfving
Journal:  Int Arch Occup Environ Health       Date:  2007-08-04       Impact factor: 3.015

Review 2.  Progress in chronic obstructive pulmonary disease genetics.

Authors:  Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2006-07

3.  Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France.

Authors:  A Guénégou; B Leynaert; J Bénessiano; I Pin; P Demoly; F Neukirch; J Boczkowski; M Aubier
Journal:  J Med Genet       Date:  2006-08       Impact factor: 6.318

4.  Do Glutathione S-Transferase Genes Modify the Link between Indoor Air Pollution and Asthma, Allergies, and Lung Function? A Systematic Review.

Authors:  Xin Dai; Gayan Bowatte; Adrian J Lowe; Melanie C Matheson; Lyle C Gurrin; John A Burgess; Shyamali C Dharmage; Caroline J Lodge
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-20       Impact factor: 4.806

Review 5.  Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.

Authors:  V L Kinnula
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 6.  Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review.

Authors:  A R Bentley; P Emrani; P A Cassano
Journal:  Thorax       Date:  2008-06-19       Impact factor: 9.139

7.  GSTM1 and GSTP1 polymorphisms as potential factors for modifying the effect of smoking on inflammatory response.

Authors:  Jin-Hee Kim; Shin-Goo Park; Kwan-Hee Lee; Ji-Ho Choi; Eun-Hee Ha; Seung-Kwon Myung; Yun-Chul Hong
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

8.  Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation.

Authors:  Michael H Cho; George R Washko; Thomas J Hoffmann; Gerard J Criner; Eric A Hoffman; Fernando J Martinez; Nan Laird; John J Reilly; Edwin K Silverman
Journal:  Respir Res       Date:  2010-03-16

9.  Associations of IL6 polymorphisms with lung function decline and COPD.

Authors:  J-Q He; M G Foreman; K Shumansky; X Zhang; L Akhabir; D D Sin; S F P Man; D L DeMeo; A A Litonjua; E K Silverman; J E Connett; N R Anthonisen; R A Wise; P D Paré; A J Sandford
Journal:  Thorax       Date:  2009-04-08       Impact factor: 9.139

10.  Chronic obstructive pulmonary disease: towards pharmacogenetics.

Authors:  Alice M Wood; See Ling Tan; Robert A Stockley
Journal:  Genome Med       Date:  2009-11-30       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.